search
Back to results

Micropulsed Laser Trabeculoplasty Using Different Parameters

Primary Purpose

Glaucoma, Open-Angle

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Micropulsed laser trabeculoplasty
Sponsored by
University of Modena and Reggio Emilia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Glaucoma, Open-Angle

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Primary open angle glaucoma
  • Pigmentary glaucoma
  • Pseudoexfoliative glaucoma

Exclusion Criteria:

  • Secondary glaucoma
  • Previous glaucoma surgery
  • Severely decompensated glaucoma
  • Corneal endothelial disease

Sites / Locations

  • Policlinico di ModenaRecruiting
  • Policlinico di ModenaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1500 mW

1000 mW

Arm Description

1500 mW of Power

Standard treatment, 1000 mW

Outcomes

Primary Outcome Measures

IOP lowering effect
Using a tonometer, we will evaluate the difference in intraocular pressure between baseline and after the treatment. The values will be expressed in mmHg.

Secondary Outcome Measures

Full Information

First Posted
December 19, 2020
Last Updated
May 20, 2021
Sponsor
University of Modena and Reggio Emilia
search

1. Study Identification

Unique Protocol Identification Number
NCT04900142
Brief Title
Micropulsed Laser Trabeculoplasty Using Different Parameters
Official Title
Micropulsed Laser Trabeculoplasty: a Randomized Double Blinded Clinical Trial Using Different Parameters
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 20, 2020 (Actual)
Primary Completion Date
March 20, 2022 (Anticipated)
Study Completion Date
June 20, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Modena and Reggio Emilia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
This randomized, double blinded, clinical trial compares two different parameters setting of micropulsed laser trabeculoplasty for open angle glaucoma. Group one is treated with 1500 mW of Power, Group two with 1000 mW. The other settings (300 micron of diameter, 300 ms of duration, 15% duty cycle) are the same for both groups, and the laser is applied for 360°. The main outcome is to evaluate the IOP (IntraOcular Pressure) lowering effects of both treatments and the safety on the corneal endothelium.
Detailed Description
This study is a randomized, double blinded, clinical trial. Eligibility criteria are: primary open angle glaucoma, pigmentary glaucoma and pseudoexfoliation glaucoma. Exclusion criteria are: secondary glaucoma, previous glaucoma surgery (not including cataract surgery as a glaucoma surgery), uncooperative patients, corneal endothelial diseases (such as Fuchs dystrophy or cornea guttata) and severely decompensated glaucoma. Both eyes of the patient are treated: each eye is allocated in a group using the closed envelopes method. Both the patient and the surgeon who performs the post laser examinations are not aware of the group allocation. The exams required before the trabeculoplasty are: best corrected visual acuity, IOP measurement, specular microscopy with corneal central thickness. The IOP is measured an hour after MLT (micropulsed laser trabeculoplasty), then on day one, at one month, at three months and six months. Best corrected visual acuity and specular microscopy are repeated at three months. Expected outcomes: to compare the IOP lowering effects between group one and two and to assess the safety of the procedure on the corneal endothelium. Secondary outcomes: decrease the number of glaucoma medications applied by the patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma, Open-Angle

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1500 mW
Arm Type
Experimental
Arm Description
1500 mW of Power
Arm Title
1000 mW
Arm Type
Active Comparator
Arm Description
Standard treatment, 1000 mW
Intervention Type
Procedure
Intervention Name(s)
Micropulsed laser trabeculoplasty
Intervention Description
Trabeculoplasty
Primary Outcome Measure Information:
Title
IOP lowering effect
Description
Using a tonometer, we will evaluate the difference in intraocular pressure between baseline and after the treatment. The values will be expressed in mmHg.
Time Frame
Up to six months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary open angle glaucoma Pigmentary glaucoma Pseudoexfoliative glaucoma Exclusion Criteria: Secondary glaucoma Previous glaucoma surgery Severely decompensated glaucoma Corneal endothelial disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Matteo Gironi, MD
Phone
0594225087
Email
matteo.gironi@hotmail.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mastropasqua Rodolfo, MD, Professor
Organizational Affiliation
Policlinico di Modena
Official's Role
Study Director
Facility Information:
Facility Name
Policlinico di Modena
City
Modena
ZIP/Postal Code
41124
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tommaso Verdina, MD, PhD
Phone
+390594225047
Email
tommaso.verdina@gmail.com
First Name & Middle Initial & Last Name & Degree
Bruno Battaglia, MD
First Name & Middle Initial & Last Name & Degree
Matteo Gironi, MD
First Name & Middle Initial & Last Name & Degree
Tommaso Verdina, MD, PhD
First Name & Middle Initial & Last Name & Degree
Cavallini Gian Maria, MD, Professor
First Name & Middle Initial & Last Name & Degree
Mastropasqua Rodolfo, MD, Professor
Facility Name
Policlinico di Modena
City
Modena
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Matteo Gironi
Phone
0594225087
Email
matteo.gironi@hotmail.it

12. IPD Sharing Statement

Learn more about this trial

Micropulsed Laser Trabeculoplasty Using Different Parameters

We'll reach out to this number within 24 hrs